 "Sun Pharma shareholders approve amalgamation scheme")
The scheme of amalgamation of Sun Pharma Global Inc with Sun Pharmaceutical Industries has been "approved by the equity shareholders with requisite majority," Sun Pharma said in a filing to the BSE.
A total of 99.99 per cent votes were polled in favour of amalgamation scheme, it added.
Sun Pharma has been present in the US since 1996, working with the country's healthcare system with a focus on generics, branded generics and over-the-counter (OTC) products.
Shares of Sun Pharmaceutical Industries were trading at Rs 857.50 per scrip in the afternoon trade on BSE, up 3.05 per cent from its previous close.
ALSO READ: Sun Pharma Q4 net down 44% at Rs 888 cr
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%